vs

Side-by-side financial comparison of Autolus Therapeutics plc (AUTL) and Community Healthcare Trust Inc (CHCT). Click either name above to swap in a different company.

Community Healthcare Trust Inc is the larger business by last-quarter revenue ($31.5M vs $21.2M, roughly 1.5× Autolus Therapeutics plc). Community Healthcare Trust Inc runs the higher net margin — 8.1% vs -373.3%, a 381.4% gap on every dollar of revenue.

Autolus Therapeutics plc is a clinical-stage biopharmaceutical company specializing in the development of next-generation engineered chimeric antigen receptor T-cell (CAR-T) therapies for the treatment of hematological malignancies and solid tumors. It operates in the global oncology biotech market, advancing a pipeline of targeted immunotherapy candidates across multiple clinical development stages.

Medical Properties Trust, Inc. (MPT) is an international real estate investment trust (REIT) based in Birmingham, Alabama that purchases and invests in healthcare facilities and for-profit healthcare holding companies, primarily in the United States and Europe. Their property acquisitions often come in the form of sale-leaseback agreements, in which the original property owner sells the property to MPT and becomes their tenant. MPT's tenants are generally subject to long-term triple net lease...

AUTL vs CHCT — Head-to-Head

Bigger by revenue
CHCT
CHCT
1.5× larger
CHCT
$31.5M
$21.2M
AUTL
Higher net margin
CHCT
CHCT
381.4% more per $
CHCT
8.1%
-373.3%
AUTL

Income Statement — Q3 FY2025 vs Q1 FY2026

Metric
AUTL
AUTL
CHCT
CHCT
Revenue
$21.2M
$31.5M
Net Profit
$-79.1M
$2.5M
Gross Margin
Operating Margin
-337.9%
Net Margin
-373.3%
8.1%
Revenue YoY
4.8%
Net Profit YoY
3.6%
60.2%
EPS (diluted)
$-0.30

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AUTL
AUTL
CHCT
CHCT
Q1 26
$31.5M
Q4 25
$30.9M
Q3 25
$21.2M
$31.1M
Q2 25
$20.9M
$29.1M
Q1 25
$9.0M
$30.1M
Q4 24
$29.3M
Q3 24
$0
$29.6M
Q2 24
$0
$27.5M
Net Profit
AUTL
AUTL
CHCT
CHCT
Q1 26
$2.5M
Q4 25
$14.4M
Q3 25
$-79.1M
$1.6M
Q2 25
$-47.9M
$-12.6M
Q1 25
$-70.2M
$1.6M
Q4 24
$1.8M
Q3 24
$-82.1M
$1.7M
Q2 24
$-58.3M
$-10.4M
Operating Margin
AUTL
AUTL
CHCT
CHCT
Q1 26
Q4 25
Q3 25
-337.9%
Q2 25
-292.6%
Q1 25
-726.3%
Q4 24
Q3 24
Q2 24
Net Margin
AUTL
AUTL
CHCT
CHCT
Q1 26
8.1%
Q4 25
46.6%
Q3 25
-373.3%
5.3%
Q2 25
-229.0%
-43.2%
Q1 25
-781.1%
5.3%
Q4 24
6.3%
Q3 24
5.9%
Q2 24
-37.9%
EPS (diluted)
AUTL
AUTL
CHCT
CHCT
Q1 26
Q4 25
$0.52
Q3 25
$-0.30
$0.03
Q2 25
$-0.18
$-0.50
Q1 25
$-0.26
$0.03
Q4 24
$0.04
Q3 24
$-0.31
$0.04
Q2 24
$-0.22
$-0.42

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AUTL
AUTL
CHCT
CHCT
Cash + ST InvestmentsLiquidity on hand
$86.1M
$2.6M
Total DebtLower is stronger
Stockholders' EquityBook value
$265.5M
$421.3M
Total Assets
$661.9M
$1.0B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
AUTL
AUTL
CHCT
CHCT
Q1 26
$2.6M
Q4 25
$3.3M
Q3 25
$86.1M
$3.4M
Q2 25
$123.8M
$4.9M
Q1 25
$95.8M
$2.3M
Q4 24
$4.4M
Q3 24
$657.1M
$2.8M
Q2 24
$705.9M
$734.0K
Total Debt
AUTL
AUTL
CHCT
CHCT
Q1 26
Q4 25
$532.2M
Q3 25
$530.1M
Q2 25
$500.1M
Q1 25
$496.0M
Q4 24
$486.0M
Q3 24
$473.7M
Q2 24
$457.6M
Stockholders' Equity
AUTL
AUTL
CHCT
CHCT
Q1 26
$421.3M
Q4 25
$429.4M
Q3 25
$265.5M
$426.8M
Q2 25
$346.5M
$437.8M
Q1 25
$371.1M
$461.3M
Q4 24
$476.0M
Q3 24
$477.0M
$477.2M
Q2 24
$527.8M
$497.8M
Total Assets
AUTL
AUTL
CHCT
CHCT
Q1 26
$1.0B
Q4 25
$990.8M
Q3 25
$661.9M
$987.3M
Q2 25
$721.0M
$966.3M
Q1 25
$746.3M
$985.1M
Q4 24
$992.6M
Q3 24
$827.5M
$981.8M
Q2 24
$853.6M
$983.2M
Debt / Equity
AUTL
AUTL
CHCT
CHCT
Q1 26
Q4 25
1.24×
Q3 25
1.24×
Q2 25
1.14×
Q1 25
1.08×
Q4 24
1.02×
Q3 24
0.99×
Q2 24
0.92×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
AUTL
AUTL
CHCT
CHCT
Operating Cash FlowLast quarter
$-67.9M
Free Cash FlowOCF − Capex
$-72.3M
FCF MarginFCF / Revenue
-341.2%
Capex IntensityCapex / Revenue
20.8%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-322.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
AUTL
AUTL
CHCT
CHCT
Q1 26
Q4 25
$56.4M
Q3 25
$-67.9M
$12.7M
Q2 25
$-72.8M
$13.8M
Q1 25
$-75.6M
$14.4M
Q4 24
$58.9M
Q3 24
$-76.7M
$13.8M
Q2 24
$-51.1M
$16.7M
Free Cash Flow
AUTL
AUTL
CHCT
CHCT
Q1 26
Q4 25
$35.9M
Q3 25
$-72.3M
$7.6M
Q2 25
$-80.1M
$9.6M
Q1 25
$-83.8M
$9.7M
Q4 24
$34.2M
Q3 24
$-86.3M
$6.7M
Q2 24
$-51.9M
$9.5M
FCF Margin
AUTL
AUTL
CHCT
CHCT
Q1 26
Q4 25
116.0%
Q3 25
-341.2%
24.6%
Q2 25
-382.6%
32.9%
Q1 25
-933.1%
32.3%
Q4 24
116.9%
Q3 24
22.5%
Q2 24
34.7%
Capex Intensity
AUTL
AUTL
CHCT
CHCT
Q1 26
Q4 25
66.3%
Q3 25
20.8%
16.3%
Q2 25
34.8%
14.5%
Q1 25
91.8%
15.6%
Q4 24
84.1%
Q3 24
24.2%
Q2 24
26.1%
Cash Conversion
AUTL
AUTL
CHCT
CHCT
Q1 26
Q4 25
3.91×
Q3 25
7.76×
Q2 25
Q1 25
9.06×
Q4 24
32.14×
Q3 24
7.92×
Q2 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons